Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Retatrutide (10 mg) is listed for laboratory research use only
Recommended for daily use and safe charging
The Microneedles used for MicroBotox are so thin that most patients dont feel anything during the treatment
4.6 Special populations Pregnancy And Lactation Glutathione injection should not be administered to a pregnant and lactating woman unless the clinical benefit outweighs the risks
US$ 23.74
US$ 22.33
US$ 23.94
US$ 21.81
US$ 22.04
US$ 27.15
